Managing adverse events in kidney cancer patients on immunotherapy/TKI combination treatment
In this video interview, Dr Eric Jonasch from MD Anderson [...]
In this video interview, Dr Eric Jonasch from MD Anderson [...]
This prospective, randomised study in 20 people looked at the [...]
During this video interview from UroToday, Dr Tian Zhang from [...]
A paper published in The Lancet Oncology this month provides [...]
In this phase 1b/2 study the researchers looked at a [...]
In this video interview with Dr Monty Pal from the [...]
The discovery of a reliable biomarker for metastatic renal cell [...]
The Sottish Medicine Consortium (SMC) have issued a final decision to recommend [...]
Cabozantinib and sunitinib are both drugs that block the development [...]
The discovery of a reliable biomarker for how patients with [...]